USANA (NYSE: USNA) CFO reports RSU vesting, stock sales around $21.34

Rhea-AI Filing Summary

USANA Health Sciences Chief Financial Officer Doug G. Iie kking reported multiple equity transactions over February 6–8, 2026. On each date, restricted stock units were exercised for 3,532, 2,231, and 4,084 shares of common stock, respectively, at an exercise price of $0 per share.

Related dispositions of common stock at $21.34 per share totaled 2,567, 1,612, and 2,746 shares on the same dates. Following these transactions, the officer directly held 2,922 shares of common stock and 41,579 restricted stock units, each representing the right to receive one share of USNA common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

IIEKKING G DOUG

(Last) (First) (Middle)

3838 WEST PARKWAY BLVD

(Street)

SALT LAKE CITY UT 84120

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF FINANCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/06/2026		M		3,532	A	(1)	3,532	D
Common Stock	02/06/2026		F		2,567	D	$21.34	965	D
Common Stock	02/07/2026		M		2,231	A	(1)	3,196	D
Common Stock	02/07/2026		F		1,612	D	$21.34	1,584	D
Common Stock	02/08/2026		M		4,084	A	(1)	5,668	D
Common Stock	02/08/2026		F		2,746	D	$21.34	2,922	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/06/2026		M			3,532	(2)	(2)	Common Stock	3,532	$0	47,894	D
Restricted Stock Units	(1)	02/07/2026		M			2,231	(3)	(3)	Common Stock	2,231	$0	45,663	D
Restricted Stock Units	(1)	02/08/2026		M			4,084	(4)	(4)	Common Stock	4,084	$0	41,579	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

2. Restricted Stock Units vest 25% on the anniversary of February 6th, 2023.

3. Restricted Stock Units vest 25% on the anniversary of February 7th, 2022.

4. Restricted Stock Units vest 25% on the anniversary of February 8th, 2024.

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transactions did USNA’s CFO report on this Form 4?

USANA Health Sciences’ CFO reported exercising restricted stock units into 3,532, 2,231, and 4,084 shares, and disposing of 2,567, 1,612, and 2,746 common shares at $21.34 per share across February 6–8, 2026.

How many USNA common shares does the CFO hold after these transactions?

After the reported transactions, the USANA Health Sciences CFO directly holds 2,922 shares of common stock. This reflects the net result of RSU conversions into common shares and related dispositions reported over February 6–8, 2026.

What restricted stock unit (RSU) activity did the USNA CFO report?

The CFO exercised restricted stock units into 3,532, 2,231, and 4,084 common shares on February 6, 7, and 8, 2026. Each RSU represents a contingent right to receive one USNA common share upon vesting under the company’s equity program.

What price is shown for the USNA common stock dispositions on the Form 4?

The Form 4 shows dispositions of 2,567, 1,612, and 2,746 USANA common shares at a price of $21.34 per share. These transactions occurred on February 6, 7, and 8, 2026, as part of the reported insider activity.

How many restricted stock units does the USNA CFO own after these trades?

Following the RSU exercises reported on this Form 4, the USANA CFO beneficially owns 41,579 restricted stock units. Each unit represents a contingent right to receive one share of USNA common stock, subject to the vesting terms described in the footnotes.

What are the vesting terms of the USNA CFO’s restricted stock units?

The RSUs vest 25% annually on specific anniversaries: February 6, 2023 grants, February 7, 2022 grants, and February 8, 2024 grants. Each vested restricted stock unit converts into one share of USANA common stock under these vesting schedules.